Summary: CBF increases concomitantly with cortical spreading depression (CSD). We tested the hypothesis that CBF changes during CSD are mediated by nitric ox ide (NO). Male Wistar rats (n = 23) were subjected to KCI-induced CSD before and after administration of ni tric oxide synthase (NOS) inhibitors N-nitro-L-arginine (L-NNA) or N-nitro-L-arginine methyl ester (L-NAME) and in nontreated animals. CBF, CSD, and mean arterial blood pressure were recorded. Brain NOS activity was measured in vitro in control, L-NNA, and L-NAME-CBF increases concomitantly with the induction of cortical spreading depression (CSD) (Hansen et aI., 1980). Nitric oxide (NO) plays an important role in regulating CBF (Faraci, 1991) , and there is rea son to believe that the increase in CBF observed with CSD may be mediated by NO. A possible mechanism linking CSD to NO is the coupling of NO to alterations of intracellular Ca2+ . NO is syn thesized from L-arginine by nitric oxide synthase (NOS) (Moncada et aI., 1991). Extracellular Ca2+ dramatically decreases during CSD (Hansen and Zeuthen, 1981). As a result, elevation of intracellu lar Ca2+ stimulates NOS activity, which increases release of NO. The increase in NO thereby causes vasodilation and an increase in CBF. 
treated rats by the conversion of [3H]arginine to eH]citrulline. Our data show that the NOS inhibitors did not significantly change regional CBF (rCBF) during CSD, even though cortical NOS activity was profoundly depressed and systemic arterial blood pressure was sig nificantly increased. Our data suggest that rCBF during CSD in rats is not regulated by NO. Key Words: CBF changes-Cortical spreading depression-Nitric oxide synthesis.
The objective of the present study was to test the hypothesis that CBF changes during CSD are me diated by an increase in NO. This hypothesis was tested indirectly by administering inhibitors of NOS and measuring CBF during the induction of CSD. If NO contributes to CBF alterations during CSD, then blocking NO synthesis should reduce the CBF increase associated with CSD.
MATERIALS AND METHODS

General preparation
Nonfasted male Wistar rats were anesthetized with halothane (3.5% induction, 1.5% during surgery, and 0.8-1.0% during electrophysiologic recordings) and were allowed to breathe spontaneously a 3: 1 N 2 0/0 2 mixture. The right femoral artery and vein were cannulated with PE-50 catheters. The arterial catheter was used for continuous monitoring of mean blood pressure and for sampling arterial blood before and after administration of N-nitro-L arginine (L-NNA) or N-nitro-L"arginine methyl ester (L-NAME). The venous catheter was em ployed for administration of L-NNA and L-NAME.
Rectal temperature was maintained at 37.0 ± 0.5°C. Animals were mounted in a stereotaxic frame for induction of CSD and measurement of CBF.
DC potential recording
A midline incision was performed to expose the skull. Three cranial electrode burr holes (I-mm di ameter) were made as follows: for front and rear active electrodes, 1.5 mm anterior and 3 mm lateral and 1.5 mm posterior and 3 mm lateral to the bregma in the right hemisphere, respectively; for the reference electrode, 1.5 and 3 mm lateral to the bregma in the left hemisphere. Ag-AgCl electrodes, made from Teflon-coated silver wire (Ag5T, Med wire, Mount Vernon, NY, U.S.A.), were inserted into the epidural space through the burr holes. The burr holes and the electrodes were then sealed in position with cranioplastic cement (Plastic One, Roanoke, VA, U.S.A.). The electrodes were al lowed to stabilize for 30 min in each animal before induction of CSD. Cortical direct current potential was recorded. The two channels of the DC electric signals were processed with high input impedance (> 1,000 Mil) preamplifiers and subsequently DC amplified in a frequency range of 0-10 Hz (Gould, Inc., Cleveland, OH, U.S.A.). The amplified analog outputs were continuously recorded on a multi channel chart recorder (Gould, Inc.).
rCBF recording
Regional CBF (rCBF) was measured by laser Doppler flowmeter (Peri Flux PF3). The laser Dopp ler probe was positioned 1.5 mm posterior, 5 mm lateral to the bregma, and 0.5 mm above the dural surface in the right hemisphere. rCBF changes were continuously recorded on a multichannel chart re corder (Gould, Inc.).
Experimental protocol
A 3-mm burr hole for KCI superfusion was made 4 mm posterior and 3 mm lateral to the bregma in the right hemisphere. The dura was carefully re moved. Latex tubing (3 mm inner diameter) cut to a height of 1.5 mm was glued to the skull to create a superfusion well around the superfusion burr hole. CSD was induced in the right neocortex by filling the superfusion well with 100 ILl of 2.5 M KCI for 30 s. The solution of KCI was then rapidly washed out using 0.9% NaCl. One episode of CSD was induced. L-NNA 10 mg/kg (n = 12) or L-NAME 20 mg/kg (n = 7) was administered i. v. 30 min after the first episode of CSD. CSD was reinduced at 1 h and 2 h after administration of L-NNA or L-NAME. The control animals (n = 4) received identical treatment without administration of L-NNA or L-NAME.
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Assay for NOS activity
Rats treated with L-NNA (n = 4) or L-NAME (n = 5) and control rats (n = 4) were randomly se lected for NOS activity assays. Immediately after the experiment, � 100 mg of cortical gray matter from each hemisphere was removed and rapidly fro zen, NOS activity was determined using the con version of eH]arginine (58.4 Ci/mmol, NEN Du pont) to [3H]citrulline (Bredt and Snyder, 1989) . Cortical samples were homogenized in 500 ILl of buffer containing 50 mM HEPES and 1 mM EDT A at pH 7.4, Homogenates were centrifuged at 2,000 rpm for 5 min and the supernatant was used for the reaction mixture, The reaction mixture consisted of 100 ILl of HEPES (50 mM), EDT A (1 mM), �-NADPH (1 mM), and Ca2+ (1 mM) at pH 7.4; 25 ILl of 100 nM eH]arginine (1 mCi/ml); and 25 ILl of supernatant. Samples were assayed in duplicate at room temperature with a reaction time of 10 min by a blinded observer. The reaction was stopped using 2 ml of HEPES (20 mM) and EDT A (2 mM), The mixture was then applied to I-ml columns of Dowex AG50WX-8 (Na + form) (Biorad, Richmond, CA, U.S.A.) and eluted with 2 ml of distilled water.
[3H]Citrulline was quantified in the eluate by liquid scintillation spectroscopy of the 4-ml eluate. NOS activity was expressed as cpm mg-I/I0 min.
Data analysis
One-way analysis of variance was performed to compare the means across the groups, followed by Bonferroni corrected t tests; differences were con sidered significant at p < 0.05. All data are pre sented as mean ± SD. Table 1 summarizes the physiological parameters before and 2 h after administration of L-NNA and L-NAME. No significant differences in arterial blood gases were detected before and after admin istration of L-NNA and L-NAME. Administration of L-NNA and L-NAME produced a significant (p < 0.05) increase in MABP. Figure 1 shows MABP, rCBF, and CSD alter ations before, 1 h, and 2 h after administration of L-NNA from a representative rat. The initial KCI application evoked a transient negative DC deflec tion of maximum amplitude 13 ± 5.83 mV lasting 0.67 ± 0.18 min (n = 19). The peak of rCBF during CSD increased 33 ± 3.5% (n = 19) of pre-CSD control value during CSD. Administration of L-NNA and L-NAME decreased baseline rCBF be low pre-CSD control value by 23 ± 9.8% (n = 12) and 20 ± 8% (n = 7), respectively, but did not Values are mean ± SD. L-NNA, N-nitro-L-arginine; L-NAME, N-nitro-L-arginine methyl ester.
RESULTS
suppress rCBF response to CSD induced by KCl application. The peak of rCBF increased 40 ± 14.5%, 45.9 ± 12.6% (n = 12), and 43 ± 11.5%, 42 ± 14.2% (n = 7) from immediate pre-CSD control values during CSD performed at 1 and 2 h after administration of L-NNA and L-NAME, respec tively. The transient negative DC deflection of max imum amplitudes were 15.5 ± 4.8 m V, 16.7 ± 4.7 mY, and 16.8 ± 10.1 mY, 12.5 ± 3.9 mV at 1 and 2 h after administration of L-NNA and L-NAME, re spectively. Figure 2 shows that there � ere no sig- nificant differences in the peak changes of rCBF (percent of pre-CSD value) during and after CSD among the control, L-NNA, and L-NAME groups measured at 1 and 2 h after administration of L-NNA or L-NAME. Post CSD hypoperfusion was not altered by administrating L-NNA or L-NAME. Administration of L-NNA and L-NAME signifi cantly inhibited NOS activity (p < 0.05). Cortical NOS activity was 108 ± 17.4 (n = 4), 20 ± 7 (n = 4), and 13 ± 6.2 (n = 5) cpm/mg/l0 min for the control animals and the animals 2 h after adminis tration of L-NNA or L-NAME, respectively.
DISCUSSION
In the present study, we examined the effect of inhibition of NOS in the rat on the rCBF response to CSD induced by application of concentrated KCI. The study was based on the premise that in tracellular Ca2 + increases during CSD, which trig gers calcium-dependent NOS activity, resulting in an increase of NO, and that the increased synthesis of NO mediates rCBF response to CSD.
Contrary to our expectations, administrations of L-NNA and L-NAME did not prevent the rCBF increase during CSD. The inability of the NOS in hibitors to prevent the rCBF increase during CSD cannot be attributed to the dose or the route of ad ministration used in the present study because ad ministrations of L-NNA and L-NAME significantly increased MABP and decreased baseline CBF, and decreased the cortical NOS activity.
The decrease of cortical NOS activity may ex plain why L-NNA and L-NAME reduced baseline CBF by 23 and 20%, respectively. Reduction of NO likely causes an increase of cerebrovascular tone and a concomitant decrease in rCBF. However, the reduced cortical NOS activity did not prevent the increase of rCBF during CSD induced by the appli cation of KCI. This indicates that rCBF during CSD is not regulated by NO and that there are indepen dent multiple mechanisms responsible for vasodila tion of cerebral vessels in rats.
The inhibition of NO synthesis without altering the hypoperfusion after CSD also suggests that NO is not involved in rCBF change after CSD. If NO mediated the hypoperfusion after CSD by vasodila tion, reduction of NOS activity might have had the lower hypoperfusion than in control ones because 90% of the arterioles constricted after CSD in the rat (Wahl et aI., 1987) .
Other investigators have reported that L-NAME suppresses the CBF pulse observed during CSD (Goadsby et aI., 1992; Duckrow, 1993) . Why our results should differ from those reports is not clear. However, it should be noted that there are several differences between our study and the others: (a) In our study, two different NOS inhibitors were ad ministered to the animals (L-NAME, L-NNA). L-NAME is a muscarinic antagonist (Buxton et aI., 1993) , and the specificity of L-NAME to suppress NOS activity would be confirmed if effects of L-NAME are reversed by L-arginine. In the other studies, the effects of L-NAME were not abolished by L-arginine (Duckrow, 1993) , and L-arginine was not administered (Goadsby et aI., 1992) . In the present study, however, we used L-NNA, which is not an alkyl ester of L-arginine and is a specific inhibitor of NOS activity. (b) Different species were employed in the studies. In our study with the rat, the changes of MABP, baseline CBF, and cortical NOS activity are consistent with those of other re ports of administration of L-NNA and L-NAME in the rat (Wang et aI., 1992; Irikura et aI., 1994) . In cats, unlike rats, the role of the L-arginine-NO pathway in regulation of blood pressure is limited (Gelderen et aI., 1991) . Administration of L-NAME at same dose and route as Goadsby et al. (10 mg/kg Lv.) did not increase MABP in cats anesthetized with a-chloralose and pentobarbitone (Gelderen et aI., 1991) . Goadsby et aI. (1992) have reported that administration of L-NAME (10 mg/kg i.v.) com pletely inhibited the hyperemia associated with CSD in anesthetized cats. However, the reduction in the peak of CBF during CSD was not statistically significant in awake rats treated with L-NAME (30 mg/kg Lv.) (Duckrow, 1993) . (c) The difference in the data may also be attributed to the methods em ployed to iHduce CSD. In the other studies, CSD was induced by a needle stick (Goadsby et aI., 1992) , or by a current stimulator (Duckrow, 1993) , and in the present study by the application of con centrated KCI.
In summary, our data demonstrate that NO is involved in the regulation of basal CBF and that inhibition of cortical NOS activity did not suppress rCBF response to CSD induced by the application of concentrated KCl. Accordingly, the vasodilation during CSD is modulated by mechanisms other than NO.
